Senior Director, Benefit/Risk Medical Adviser to the QPPV

Build our future together: At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a Senior Director, Benefit/Risk Medical Adviser EU/UK to join our QPPV Office. Reporting directly to the EU/UK QPPV, you will provide authoritative medical, safety and benefit-risk advice supporting oversight of authorised products throughout their lifecycle.

When & where: Munich (Hybrid)

Discover your role:

Advise the QPPV on signal validation, evaluation and prioritisation, benefit-risk assessments, Risk Management Plans and health hazard assessments. Shape medical and safety strategy across clinical development and the post-authorisation lifecycle, including emerging clinical trial data and evolving safety evidence. Provide expert input to regulatory submissions, aggregate safety reports, safety communications and responses to health authority questions, requests and referrals. Apply qualitative and quantitative benefit-risk approaches using clinical, epidemiological, real-world and patient-preference evidence, where appropriate. Advise on PASS protocols and the appropriate use and interpretation of epidemiology, pharmacoepidemiology and real-world data. Develop and optimise CCSI, RMP, aggregate reporting and pharmacovigilance processes, identifying gaps and strengthening QPPV oversight. Partner across safety, regulatory, clinical, quality, legal, commercial, local pharmacovigilance and product supply functions while contributing to governance and inspection readiness. Provide credible medical challenge, translate complex safety science into clear advice and influence senior stakeholders without direct authority.

This role requires:

• A medical qualification, such as MBChB, MBBS or MD, with a current or historic medical licence.
• Extensive post-qualification experience in drug safety or pharmacovigilance within the pharmaceutical or biotechnology industry, or a health authority.
• Deep knowledge of EU GVP and the EU/UK pharmacovigilance legislative framework, with working knowledge of US FDA safety reporting requirements.
• Proven expertise in signal evaluation, qualitative and quantitative benefit-risk assessment, risk management planning and the safety aspects of regulatory submissions.
• Strong knowledge of relevant ICH guidelines and the application of real-world, epidemiological and pharmacoepidemiological evidence.
• Authoritative medical judgement, clear scientific communication and the ability to operate credibly with senior and cross-functional stakeholders.
• Experience supporting or deputising for a QPPV, working within a QPPV Office, or supporting inspections and audits is preferred.
• A Pharmaceutical Medicine qualification, specialist registration or experience across additional regulatory jurisdictions is preferred.
• Experience applying patient-preference evidence or quantitative benefit-risk methods, or an additional EU language relevant to the location, is preferred.

Does this sound like you?

Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, sexual orientation, gender identity or expression, gender reassignment, marital or civil partnership status, civil status, pregnancy or parental status, age, disability, nationality, citizenship status, ethnic or national origin, membership of the Traveler community, familial status, genetic information, military or veteran status, or any other characteristic protected under applicable law.

Where required, we will provide reasonable accommodation to applicants with known disabilities or chronic illnesses during the recruitment process, unless such accommodation would impose undue hardship.

Where necessary, we disclose salary ranges for roles in all countries in which we operate. The final offer will be determined within the relevant range based on the country of employment, specific role level, and your skills and experience. In some countries, collective bargaining agreements (CBAs) may apply and influence certain elements of pay or benefits.

Salary Range

Salary Range (annually) €157,500.00 - €262,500.00

Regeneron offers a competitive and comprehensive total rewards package which may include, depending on country and role:

• annual bonuses or other incentive plans
• equity awards
• pension or retirement benefits
• 401(k) company match
• health and wellness programs
• fitness centers
• insurance benefits (e.g. medical, dental, vision, life and disability)
• paid time off
• family support benefits

For additional information about Regeneron benefits in the U.S., please visit For other locations, additional information will be provided during the recruitment process.

Please be advised that at Regeneron, we believe we do our best work when we are together.

For that reason, many roles are required to be performed on‑site.

As part of the recruitment process, certain background checks may be conducted in accordance with the laws of the country where the position is based. The purpose of such checks is to verify certain information prior to the commencement of employment such as identity, right to work and educational qualifications.

For jobs in Canada: this posting is for an existing position. Salary Range (annually) €157,500.00 - €262,500.00

Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurology, infectious diseases and rare diseases. Regeneron is also proud of award winning culture of innovation, being recognized as a Great Place to Work in 2021, Fast Company’s Best Workplace for Innovators in 2020, and Forbes JUST companies in 2020, among others.